The 2024 FGS
Annual Meeting


Join the FGS Today!

Become a member of Florida’s premier network of over 500 Gastroenterologists.

Connect, Collaborate, Contribute.

FGS Logo

Become a part of the conversation shaping the future of gastroenterology.

Join a dynamic community where you’re not just staying current with industry trends but actively shaping them. Here, your pursuit of collaborative opportunities and innovative ideas directly contributes to the evolution of gastroenterology.

Membership Benefits

Join the FGS Community to connect, collaborate, and expand your professional network in the gastroenterological field. Create a personalized profile, exchange private messages with colleagues, and participate in specialized groups or forum discussions.


Networking & Collaboration


Leadership Opportunities


Continual Education


Excellence in Practice

About the FGS

The Florida Gastroenterologic Society was originally conceived in 1965 by James L. Borland, M.D., a well respected Gastroenterologist who practiced in Jacksonville, Florida. Today, the FGS stands as a beacon of support, education, and advocacy, providing a platform for continuous professional development, networking and a voice in shaping the field of gastroenterology.

Ready to Join Other Leaders in Gastroenterology?​

Whether you’re seeking to enrich your knowledge, expand your professional network, or influence the future of gastroenterology, FGS is where your aspirations meet opportunity.

Take the Next Step in Your Professional Journey

Member Spotlight & Announcements

Abhi Patil, MD

Dr. Abhitabh Patil Becomes The New FGS President

Erim tolga

Dr. Erim Tolga Joins Board as Incoming Officer

FGS Updates

Spring FGS Meeting Highlight: Unveiling STELARA® (ustekinumab) As A First Line Biologic Option with Real-World Evidence

Join us for an exclusive live educational program at the upcoming Spring FGS Meeting, featuring esteemed Gastroenterologist Dr. Ronen Arai from Digestive CARE of N. Broward, Coral Springs, FL.  Dr. Arai will delve into the cutting-edge treatment STELARA® (ustekinumab), showcasing its efficacy as a first-line biologic option for adults with moderately to severely

Read More »